Drug Law Weekly

Center for Applied Biomedical Research, Bologna, Italy - Reports from Italy, Spain and the New Zealand describe recent advances in obesity research

Center of Infection and Immunity, Amsterdam, Netherlands - Recent studies from Netherlands, Qatar and South Korea add new data to meningitis research

Center of Molecular Immunology, C Habanna, Cuba - Researchers' data from Cuba, the South Korea and the United States advance vaccines research

Charite University Hospital, Berlin - Infection management is challenging in cancer and stem cell transplant patients

Charite University of Medicine, Germany - Researchers from Germany and the United States report recent findings in apoptosis

Charite University of Medicine, Germany - Researchers' work from Germany, Canada and the United States adds to prostate cancer body of knowledge

Charite-Universitatsmedizin, Berlin - CCR6 a potential target for specific therapeutic interventions for colorectal cancer

Chelsea & Westminster Hospital, London - AIDS-associated KS prognostic index predicts mortality at initial diagnosis

Chinese Academy of Science - Ca²⁺ handling in myocardial injured rats was improved by trimetazidine

Christie Hospital NHS Trust, Manchester, England - Researchers from the United Kingdom, Norway and United States provide details of new studies and findings in the area of cancer treatment

Cleveland Clinic, U.S. - Research from the United States add new data to cardiology body of knowledge

Clinique Les Fontaines, Melun - Transulnar artery approach for coronary interventions is safe and effective

Coalition of Cancer Cooperative Groups - Coalition of Cancer Cooperative Groups features Lance Armstrong in Newsweek supplement

Collaborations - Advanced BioPhotonics, Hospital of The University of Pennsylvania enter research deal

Consortium for Conservation Medicine, New York - West Nile Virus epidemics in North America driven by shifts in mosquito feeding behavior

CuraGen Corporation - CuraGen initiates second Phase II clinical trial with Velafermin

Curtin University of Technology of Technology, Australia - Findings from Australia and the United States advance knowledge in heart disease research

Cutting Edge Information - U.S.-based drug companies ink copromotion deals to tap European markets

Cyberonics, Inc. - Cyberonics funds study for VNS therapy in treatment-resistant depression

Cytori Therapeutics, Inc. - First three patients treated in clinical safety and feasibility study for breast reconstruction

Dana-Farber Cancer Institute, Boston - New targeted therapy shows promise in children with metastatic gastrointestinal stromal tumor

HIV/AIDS Education - Microsoft and PBS create global web resource to enhance understanding of AIDS pandemic

Health Protection Agency - New findings in HIV/AIDS described from the United States, United Kingdom and Brazil

Healthcare Costs - GPhA hails Omnitrope approval as significant step in opening door to consumer savings

LDR Spine - LDR Spine launches study for cervical artificial disc

Lung Cancer - Point Therapeutics receives fast track designation for talabostat for non-small cell lung cancer

Market Analysis - Investor advisor envisions market reactions to fears of an avian flu pandemic

Medicare - LifePoint Hospitals' Arizona facility earns Medicare certification

Memory Pharmaceuticals Corp. - Memory Pharmaceuticals delays initiation of phase IIa trial of MEM 3454 for Alzheimer disease

Merck & Co., Inc. - FDA approves Zostavax, Merck's new vaccine for preventing shingles in adults 60 and older

Pain Management - ISTA begins phase III trials of a once-daily Xibrom for ocular pain and inflammation

U.S. Food & Drug Administration -  Campylobacter jejuni induces cytokine production in dendritic cells

U.S. Food & Drug Administration - Allometric methods to predict drug clearance in children are compared

U.S. Food & Drug Administration - Dextran 1 given before clinical dextrans reduces anaphylactic shock risk

U.S. Food and Drug Administration - Reports from the United States and Australia add new data to cancer treatment research

University of Texas, Austin - Cancer drug extends cognitive function in patients with brain metastases

Viragen, Inc. - Viragen reports continued U.S. Army studies of Multiferon

Wall Street Journal Online - The U.S. Food and Drug Administration's reputation with the general public is under attack